Your browser doesn't support javascript.
loading
An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants.
Pop, Ana; Williams, Monique; Struys, Eduard A; Monné, Magnus; Jansen, Erwin E W; De Grassi, Anna; Kanhai, Warsha A; Scarcia, Pasquale; Ojeda, Matilde R Fernandez; Porcelli, Vito; van Dooren, Silvy J M; Lennertz, Pascal; Nota, Benjamin; Abdenur, Jose E; Coman, David; Das, Anibh Martin; El-Gharbawy, Areeg; Nuoffer, Jean-Marc; Polic, Branka; Santer, René; Weinhold, Natalie; Zuccarelli, Britton; Palmieri, Ferdinando; Palmieri, Luigi; Salomons, Gajja S.
Afiliação
  • Pop A; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU Medical Center Metabolic Unit PK 1X009, Postbus 7057, 1007 MB, Amsterdam, The Netherlands.
  • Williams M; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU Medical Center Metabolic Unit PK 1X009, Postbus 7057, 1007 MB, Amsterdam, The Netherlands.
  • Struys EA; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU Medical Center Metabolic Unit PK 1X009, Postbus 7057, 1007 MB, Amsterdam, The Netherlands.
  • Monné M; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
  • Jansen EEW; Department of Sciences, University of Basilicata, Potenza, Italy.
  • De Grassi A; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU Medical Center Metabolic Unit PK 1X009, Postbus 7057, 1007 MB, Amsterdam, The Netherlands.
  • Kanhai WA; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
  • Scarcia P; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU Medical Center Metabolic Unit PK 1X009, Postbus 7057, 1007 MB, Amsterdam, The Netherlands.
  • Ojeda MRF; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
  • Porcelli V; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU Medical Center Metabolic Unit PK 1X009, Postbus 7057, 1007 MB, Amsterdam, The Netherlands.
  • van Dooren SJM; Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, Bari, Italy.
  • Lennertz P; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU Medical Center Metabolic Unit PK 1X009, Postbus 7057, 1007 MB, Amsterdam, The Netherlands.
  • Nota B; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU Medical Center Metabolic Unit PK 1X009, Postbus 7057, 1007 MB, Amsterdam, The Netherlands.
  • Abdenur JE; Metabolic Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, VU Medical Center Metabolic Unit PK 1X009, Postbus 7057, 1007 MB, Amsterdam, The Netherlands.
  • Coman D; Division of Metabolic Disorders, CHOC Children's, Orange, CA, USA.
  • Das AM; Department of Pediatrics, University of California at Irvine, Irvine, CA, USA.
  • El-Gharbawy A; Department of Metabolic Medicine, Lady Cilento Children's Hospital, Brisbane, Australia.
  • Nuoffer JM; School of Medicine, University of Queensland Brisbane, Griffith University Gold Coast, Gold Coast, Australia.
  • Polic B; Clinic for Pediatric Kidney-, Liver- and Metabolic Diseases, Hannover Medical School, Hannover, Germany.
  • Santer R; Department of Pediatrics and Division of Medical Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Weinhold N; Division of Pediatric Endocrinology, Diabetology and Metabolism and University Institute of Clinical Chemistry, Inselspital, University Hospital, University of Bern, Bern, Switzerland.
  • Zuccarelli B; Department of Pediatrics, PICU, University Hospital Centre, Split, Croatia.
  • Palmieri F; Department of Pediatrics, University Medical Center Hamburg Eppendorf, Hamburg, Germany.
  • Palmieri L; Sozialpädiatrisches Zentrum, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Salomons GS; The University of Kansas School of Medicine Salina Campus, Salina, USA.
J Inherit Metab Dis ; 41(2): 169-180, 2018 03.
Article em En | MEDLINE | ID: mdl-29238895
Combined D-2- and L-2-hydroxyglutaric aciduria (D/L-2-HGA) is a devastating neurometabolic disorder, usually lethal in the first years of life. Autosomal recessive mutations in the SLC25A1 gene, which encodes the mitochondrial citrate carrier (CIC), were previously detected in patients affected with combined D/L-2-HGA. We showed that transfection of deficient fibroblasts with wild-type SLC25A1 restored citrate efflux and decreased intracellular 2-hydroxyglutarate levels, confirming that deficient CIC is the cause of D/L-2-HGA. We developed and implemented a functional assay and applied it to all 17 missense variants detected in a total of 26 CIC-deficient patients, including eight novel cases, showing reduced activities of varying degrees. In addition, we analyzed the importance of residues affected by these missense variants using our existing scoring system. This allowed not only a clinical and biochemical overview of the D/L-2-HGA patients but also phenotype-genotype correlation studies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Cítrico / Encefalopatias Metabólicas Congênitas / Proteínas de Transporte de Ânions / Proteínas Mitocondriais / Glutaratos Tipo de estudo: Prognostic_studies Limite: Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: J Inherit Metab Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Cítrico / Encefalopatias Metabólicas Congênitas / Proteínas de Transporte de Ânions / Proteínas Mitocondriais / Glutaratos Tipo de estudo: Prognostic_studies Limite: Child, preschool / Female / Humans / Infant / Male / Newborn Idioma: En Revista: J Inherit Metab Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda